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Abstract 
Fluoxetine, a widely used antidepressant that primarily acts as a 
selective serotonin reuptake inhibitor, inhibits various membrane receptors 
and Ca2+ influx by unknown mechanism. In addition, it has been shown that 
Ca2+ is control mitochondrial metabolism and respiration. Here, effect of 
fluoxetine on the voltage gated Calcium channels in MIN6 cells was 
examined. Using Ca2+ imaging is to assess intracellular calcium. Fluoxetine 
30 µM inhibited ca2+ levels. These results indicated a tighter binding of 
fluoxetine to the Calcium than to the resting state of other channels, 
suggesting a more potent inhibition of Ca2+ channels at physiological resting 
membrane potential. Altogether, these data demonstrate that clinically 
relevant concentrations of fluoxetine exert a voltage-dependent block of 
channels that may contribute to this antidepressant’s pharmacological effects.
 
Keywords: Fluoxetine, Ca2+ channels, mitochondria, insulin secretion, 
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Introduction 
Fluoxetine is a psychoactive drug widely prescribed in many 
psychiatric disorders, including depression, obsessive-compulsive disorder 
and bulimia nervosa. The therapeutic action of fluoxetine primarily results 
from the inhibition of serotonin reuptake (Stark, Fuller et al. 1985, Wong, 
Bymaster et al. 1995), thus enhancing serotoninergic neurotransmission. 
Besides this mechanism, fluoxetine has several other modulatory effects, such 
as inhibition of G protein-coupled receptors (Stanton, Bolden-Watson et al. 
1993, Pälvimäki, Roth et al. 1996), blockade of monoamine oxidases 
(Mukherjee and Yang 1999), and modulation of several ionic channels. 
Indeed, it has been reported that fluoxetine is a potent blocker of K channels 
(Thomas, Gut et al. 2002, Choi, Choi et al. 2003, Kobayashi, Washiyama et 
al. 2003, Kennard, Chumbley et al. 2005), Na+ channels (Pancrazio, Kamatchi 
et al. 1998) and Ca2+ channels (Deák, Lasztóczi et al. 2000). T-type Ca2+ 
channels, a subgroup of voltage-gated Ca2+ channels, are the target of many 
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antipsychotic drugs. For example, study by Deak et al. (2000) reporting that 
fluoxetine inhibits T-type Ca2+ currents in rat hippocampal pyramidal cells. 
The widely accepted key process of glucose stimulated insulin 
secretion from the beta cell upon glucose stimulation is ATP-sensitive K+ 
channel (K+-ATP) dependent. In beta cells, the glut-2 transporter facilitates 
glucose entry. The glucose is then phosphorylated to glucose -6- phosphate by 
the enzyme glucokinase (GK), which has a Km of approximately 5 mM for 
glucose explains the concentration dependence of the β-cell response to 
glucose in the physiological range to stimulate insulin release (Matschinsky, 
Liang et al. 1993, Aguilar-Bryan and Bryan 1999). Pyruvate is formed from 
glucose, which is either transformed to lactate by anaerobic glycolysis or 
enters the mitochondria and is formed by tricycaboxylic acid (TCA) cycle to 
activate the respiratory chain in order to generate adenosine triphosphate 
(ATP). Increased ATP/ADP ratio causes closure of the K+-ATP sensitive 
channel, leading to a depolarization of cell membrane (Aguilar-Bryan and 
Bryan 1999), allowing the L- type Ca2+ channels in the cell membrane to open, 
causing an increase in cytosolic Ca2+. This promotes exocytosis of insulin 
secretory vesicles. 
Therefore, it is of importance to characterize fluoxetine’s action on the 
Ca2+ influx and their inhibition by fluoxetine should be investigated for a 
better understanding of this antidepressant’s therapeutic action and side 
effects.  In this article, it has been reported the first electrophysiological study 
of the inhibitory effects of fluoxetine on Ca2+ influx of MIN 6 pancreatic beta 
cells. 
 
Methodology 
Cell line 
The MIN6 (Mouse pancreatic beta ) cell line is a well-established, time 
honored, model for the study of pancreatic b-cell function (Miyazaki, Araki et 
al. 1990, Ishihara, Asano et al. 1993, Daunt, Dale et al. 2006, Cataldo, Cortés 
et al. 2015). The main advantage of a cell line for pancreatic b-cell research is 
that it large numbers of phenotypically homogenous cells are available which 
are devoid of paracrine and neuroendocrine effects that arise from interaction 
with the other endocrine and neuronal cell types that reside within the 
pancreatic islet (Ishihara, Asano et al. 1993). Although MIN6 have been 
reported to contain and secrete other pancreatic endocrine hormones, these 
cells still remain primarily b-cell in function (Nakashima, Kanda et al. 2009). 
Cells were grown, and the chronic experiments performed, in Dulbecco’s 
modified Eagle’s medium (DMEM) which contained 25mM glucose and was 
supplemented with: 2mM L glutamine, 10% fetal calf serum, 50 mM 2-
mercaptoethanol, and 25mM HEPES. In this study, cells from passage 
numbers 35–42 were used. 
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Intracellular Ca2+ measurements 
To enable imaging (Smith, Proks et al.)i of MIN6 cells, cells were 
loaded with the fluorescent Ca2+ indicator dye Fluo-4 AM (acetoxymethyl). 
Fluo-4 is an analog of Fluo-3 with the two chlorine substituents replaced by 
fluorines. Manufacturers report increased fluorescence excitation at 488 nm 
resulting in higher fluorescence signal levels (Invitrogen). Fluo-4 AM can be 
used at lower dye concentrations to generate the same fluorescence signal 
intensity (Gee, Brown et al. 2000). Lower loading concentrations and dye 
loading times of Fluo-4 AM make its use in cells a less invasive practice (Gee, 
Brown et al. 2000). 
To monitor changes in the bulk intracellular Ca2+, we used the Ca2+ 
fluorophore Fluo-4, as previously descried (Duchen, Smith et al. 1993, Smith, 
Duchen et al. 1995). MIN6 cells, they were plated onto 22 mm glass cover-
slips. The cells were incubated with Fluo 4-AM (at a final concentration of 
1μM in 0.1% BSA (wt/vol), 10 mM glucose, Hank’s solution) for 20 minutes 
in the dark at room temperature (21oC-22oC). Loading was performed at room 
temperature to decrease the likelihood of dye compartmentalisation in 
accordance with the manufacturer’s recommendations (Invitrogen). The cells 
were washed by perifusion for 10 minutes in Ca2+-containing Hank’s solution. 
To perifuse the microscope chamber, solutions were gravity-fed through 
polythene tubing. All drug additions were made via bath perifusion. Exchange 
between solutions was performed using an electrically controlled two-way 
valve. 
The MIN6 cells were unresponsive to the 50 mM K+ calibration 
procedure and 10 mM glucose; or if the Ca2+ levels continuously decreased 
throughout the experiment, MIN6 cells that did not respond to extracellular 
Ca2+ removal were also excluded. Data were output as % fluorescence, and 
expressed as mean ± S.E.M. For each protocol presented at least 4 different 
MIN6 cell preparations were used and “n” the number of MIN6 cells given as 
the sum total from these preparations. 
 
Results 
Calcium channels are inhibited by fluoxetine in response to glucose 
The Previous results suggest that fluoxetine and low Ca2+ both inhibit 
mitochondrial function of MIN6 cells. The aim of these experiments was to 
assess the effect of fluoxetine on Ca2+ influx in presence of 10 mM glucose. 
At basal glucose concentrations, Ca2+ transients were usually absent (Fig. 1A). 
Addition of 10 mM glucose after a 1 minute delay caused transient fell and 
followed by a significant increase in intracellular Ca2+ ~11±0.83% (p < 
0.0001, Sidak's multiple comparisons test) compared to the basal ( Fig. 
1A&B). 30 µM fluoxetine inhibited Ca2+ in the presence 10 mM glucose by 
~9.4±2.7% (p < 0.05, Sidak's multiple comparisons test) which partly 
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recovered an washout (p < 0.0001, Sidak's multiple comparisons test) (Fig. 
1A&B). Final addition of 50 mM K+ (depolarization of cell membrane to –40 
mV (Sharp 1996, Aguilar-Bryan and Bryan 1999) caused a rapid increase in 
Ca2+ levels (Fig. 1A). The experiment protocol was repeated but 50 mM K+ 
was replaced by perifusion of low Ca2+ which mimic the effect of fluoxetine 
(Fig. 2). 
Fig. 1: Effect of 10 mM glucose and 30 µM fluoxetine on the Ca2+ response in MIN6 cells. 
A) Representative effect of 10 mM glucose and 30 µM fluoxetine  on the Ca2+ influx of a 
single cell measured by the % change in fluoresence signal relative to 50 mM K+. B) Mean 
(±SEM) response to the serial additions as indicated 10 mM glucose (G.) and 30 µM 
fluoxetine (flx). N= 50 cells collected from 3 experiments where the minimum number of cells 
is 3 in each one. 
 
Figure 2: Representative effect of 10 mM glucose and 30 µM fluoxetine on the Ca2+ influx 
of a single cell. N= 40 cells collected from 3 experiments where the minimum number of cells 
is 3 in each one. 
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To verify that fluoxetine inhibits voltage calcium channels. The effect 
of 30 µM fluoxetine in response to 20 µM tolbutamide (Tb) was explored. 
Since Tb blocks K+-ATP channel and increases Ca
2+ influx and reveal any effect 
that may be seen regarding to direct block of Ca2+ voltage dependent channel 
by fluoxetine. Tolbutamide (20 µM) stimulated Ca2+ signal by ~15±1.48% (P< 
0.0001, Dunnett's multiple comparisons test) after a delay of 1 minute. 
Subsequent addition of 30 µM fluoxetine abolished the Ca2+ influx in the 
presence of tolbutamide (P< 0.0001, Dunnett's multiple comparisons test)(Fig. 
3A&B). The vehicle for the fluoxetine, water, had no effect on the Ca2+ influx 
in the presence of tolbutamide (Fig. 3C&D). 
Fig. 3: Effect of 30 µM fluoxetine on Ca2+ in presence of 20 µM tolbutamide (Tb). A, C) 
Representative effect of 20 µM Tolbutamide(Tb) and 30 µM fluoxetine (flx) or water 
respectively on the Ca2+ influx of a single cell monitored by the change in Fluo-4 fluorescence. 
B, D) Mean (±SEM) of single cells in response to the serial additions as indicated 20 µM 
Tolbutamide and 30 µM fluoxetine or H2O respectively. N= 55 cells collected from 5 
experiments where the minimum number of cells is 3 in each one. 
 
Figure 4. Shows that the percentage effect of 30 µM fluoxetine in the 
presence of 20 µM tolbutamide. The data showed that 30 µM fluoxetine 
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significantly decreased Ca2+ influx compared to the vehicle (H2O) (P< 0.0001, 
Mann Whitney test). 
 
Fig. 4: The percentage block of 30 µM fluoxetine in presence of tolbutamide (Tb) on the 
Ca2+ influx in MIN6 cells. Experimental data for this figure were sourced from figure 
14B&D. Values are shown as % change in Ca2+ levels compared to the vehicle (H2O). Data 
are presented as Mean ± SEM. 
 
Calcium co-regulates oxidative metabolism in pancreatic beta cells 
The ability of Ca2+ to control mitochondrial metabolism and respiration 
has been mainly attributed to the activation of Ca2+-regulated dehydrogenase 
(Denton 2009, Griffiths and Rutter 2009), which accelerates oxidative 
metabolism associated with the formation of the reduced NAD(P)H. The aim 
of this experiments was to investigate the effect of Ca2+ on the NAD(P)H 
levels. Fig. 5A shows that the effect of 10 mM glucose and Ca2+ free on the 
NAD(P)H levels. Once NADPH levels reached steady-state after glucose 
stimulation (p< 0.0001, Dunn's multiple comparisons test), subsequent 
addition of free Ca2+ decreased NAD(P)H levels in the presence of glucose 
(p<0.0001, Dunn's multiple comparisons test)(Fig. 5B). Re-addition of Ca2+ 
recovered the NAD(P)H levels to the control (glucose) levels (p< 0.0001, 
Dunn's multiple comparisons test)(Fig. 5A). In summary, these results suggest 
that low Ca2+ may inhibit mitochondrial respiration. 
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Fig. 5: Effect of calcium signalling on NAD(P)H responses in MIN6 cells. A) 
Representative effect of 10 mM glucose (G.) and free Ca 2+ on the NAD(P)H levels of a single 
cell. B) Mean (±SEM) NADPH fluorescence for single cells in response to the serial additions 
as indicated. N= 68 cells collected from 4 experiments where the minimum number of cells is 
15 in each one. 
 
It has been shown that metabolism affects Ca2+ entry in MIN6 cells 
(Smith, Sellers et al. 2001, De Marchi, Thevenet et al. 2014). The aim of this 
experiment was to investigate the effect of rotenone on the Ca2+ influx. Within 
a minute of addition, 10 mM glucose produced a large increase in the Ca2+ 
influx which is ~17±1.27% (P< 0.0001, Sidak's multiple comparisons test ) 
compared to the  basal (Fig. 6A&B). Subsequent addition of 1 µM rotenone 
(complex I inhibitor) significantly inhibited Ca2+ signal by ~18±2.47% (P< 
0.0001, Sidak's multiple comparisons test ) in response to 10 mM glucose (Fig. 
6A&B). Final addition of 50 mM K+ (depolarization of cell membrane) 
considerably increased the Ca2+ signal (Fig. 6A). 
Fig. 6: Effect of 1 µM rotenone on the Ca2+ in response to 10 mM glucose. A) 
Representative effect of 1 µM rotenone (rote) in the presence 10 mM glucose  on the Ca2+ 
influx of a single cell monitored by the % change in Fluo-4 fluorescence relative to 50 mM 
K+ (%100). B) Mean (±SEM) of single cells in response to the serial additions as indicated 1 
µM rotenone (rote) in the presence 10 mM glucose (G.). N= 76 cells collected from 3 
experiments where the minimum number of cells is 3 in each one. 
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Discussion 
Effect of glucose and fluoxetine on Ca2+ influx 
Fluoxetine significantly inhibited Ca2+ influx by either a direct 
inhibition of L- type voltage dependent Ca2+ channels or an indirect 
impairment of mitochondria of pancreatic beta cells. In the present 
experiments, the 11% stimulation in the level of Ca2+ produced by 10 mM 
glucose for MIN6 cells; these results are consistent with a central role for 
mitochondrial oxidative phosphorylation in coupling changes in glucose 
concentration with insulin release. For example, it has been found that, 
glucose-stimulated hyperpolarization of ∆ψm by increasing ATP/ADP ratio, 
leads to closure of K+-ATP channels, followed by depolarization cell 
membrane, leading to open L-Type Voltage Ca2+ channels and increased Ca2+ 
(Duchen, Smith et al. 1993, De Marchi, Thevenet et al. 2014). However, 30 
µM fluoxetine significantly but reversibly inhibits Ca2+ levels. Isotonic 
replacement of Na+ (by  50 mM K+) caused a rapid increase Ca2+ influx of 
these cells; an observation consistent with depolarization the cell membrane 
potential and activation of voltage-dependent Ca2+channels (Duchen, Smith et 
al. 1993). 
 
Fluoxetine blocks L- type voltage dependent Ca2+ channels 
In present study, we found that 20 µM tolbutamide increased Ca2+ 
influx; an observation consistent with previous finding which indicates that 
tolbutamide, stimulate insulin release from pancreatic β-cells predominantly 
by blocking the activity of ATP-sensitive K+ (K+-ATP) channels in the plasma 
membrane (Duchen, Smith et al. 1993, Smith, Proks et al. 1999). This causes 
membrane depolarization, activation of voltage-gated Ca2+ channels, 
increased Ca2+ influx, an increase in the cytosolic Ca2+ and insulin secretion.in 
the presence of tolbutamide. 30 µM fluoxetine significantly decreased Ca2+. 
These data suggest that fluoxetine inhibits the L-type voltage dependent Ca2+ 
channel by direct mechanism in MIN6 cells. These results are comparable with 
The IC50 values obtained with fluoxetine for blocking of other ionic channels 
in different preparations. For example, the IC50 value of fluoxetine block of T-
type voltage calcium channels is 6.8 µM and both L- and N- type voltage 
calcium channels is 3 µM in rat hippocampal pyramidal cells (Deák, Lasztóczi 
et al. 2000) and (Pancrazio, Kamatchi et al. 1998) found that 20 µM fluoxetine 
inhibited N-type voltage Ca2+ channel in bovine adrenal chromaffin cells. 
(Traboulsie, Chemin et al. 2006) indicated that 30 µM fluoxetine blocked T-
type voltage calcium channel in human embryonal kidney cells. To our 
knowledge, this is the first evidence for the inhibition of calcium channels by 
fluoxetine in MIN6 cell lines. 
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Fluoxetine inhibits Ca2+ entry by blocking metabolism 
In the present study, 10 mM glucose increased level of Ca2+  influx in 
MIN6 cells. This can be accounted for by central role of mitochondrial 
oxidative phosphorylation in coupling changes in glucose concentration with 
insulin release (Duchen, Smith et al. 1993, De Marchi, Thevenet et al. 2014). 
It has been found that inhibition of respiration by inhibiting ATP synthesis 
with rotenone rapidly decreased intracellular Ca2+ in MIN6 cells. Our results 
underline the importance of continuous mitochondrial ATP synthesis to 
maintain beta cell Ca2+ signalling.  
 
Conclusion 
These data suggest that fluoxetine inhibited Ca2+ influx by two 
mechanisms: by direct block of voltage-dependent Ca2+ channels or by direct 
inhibition of mitochondrial function. 
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